:HQL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
:HQL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
abrdn Life Sciences Investors's Forward PE Ratio for today is 0.00.
abrdn Life Sciences Investors's PE Ratio without NRI for today is 10.65.
abrdn Life Sciences Investors's PE Ratio for today is 10.65.
The historical data trend for abrdn Life Sciences Investors's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
abrdn Life Sciences Investors Annual Data | |
Trend | |
Forward PE Ratio |
abrdn Life Sciences Investors Semi-Annual Data |
Forward PE Ratio |
For the Asset Management subindustry, abrdn Life Sciences Investors's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Asset Management industry and Financial Services sector, abrdn Life Sciences Investors's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where abrdn Life Sciences Investors's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
abrdn Life Sciences Investors (NYSE:HQL) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Thank you for viewing the detailed overview of abrdn Life Sciences Investors's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Todd Reit | director | C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103 |
Bill Maher | director | 600 WEST BROADWAY, 30TH FL., SAN DIEGO CA 92101 |
Rose Dimartino | director | C/O ABRDN, 1900 MARKET STREET, PHILADELPHIA PA 19103 |
James Joseph O'connor | other: Director of Adviser | C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103 |
Marika Tooze | other: Director of Adviser | C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103 |
Aberdeen Standard Investments Inc. | other: Adviser | 1900 MARKET ST., 2ND FLOOR, PHILADELPHIA PA 19103 |
Jaclyn Marie Matsick | other: Director of Adviser | C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103 |
Lucia Sitar | officer: VP and Chief Legal Officer | 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
Jennifer A Nichols | other: Director of Adviser | 1735 MARKET STREET, 37TH FLOOR, PHILADELPHIA PA 19103 |
Christian Pittard | officer: President | ONE BOW CHURCHYARD, LONDON X0 EC4M 9HH |
Megan Kennedy | officer: Secretary and Vice President | 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
Sharon Ferrari | officer: Treasurer and CFO | 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
Alan R Goodson | officer: Vice President | 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
Joseph Andolina | officer: Chief Compliance Officer & VP | 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
Stephen Bird | director | 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10022 |
From GuruFocus
By Business Wire Business Wire • 09-30-2021
By Business Wire • 06-30-2023
By Business Wire Business Wire • 05-15-2023
By GuruFocus Research • 09-26-2023
By Business Wire Business Wire • 08-17-2021
By Business Wire Business Wire • 12-22-2020
By Business Wire Business Wire • 05-18-2021
By Business Wire • 08-15-2023
By Business Wire Business Wire • 05-17-2022
By Business Wire Business Wire • 03-31-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.